X
Pharma Advancement
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    Sorrento and Mount Sinai Team Up for Antibody Cocktail COVI-SHIELD Project

    I-Mab Reports Positive Interim Analysis from Phase 2/3 Study of its GM-CSF Antibody Plonmarlimab to Treat Patients with Severe COVID-19

    Care Access Research Launches Alliance to Provide Infrastructure for COVID-19 Trials

    Valneva Initiates Further Phase 3 Clinical Trial for its COVID-19 Vaccine Candidate

    Charities Pay $6 Million to Settle Medicare Kickback Allegations in Pharma Probe

    AzurRx expands trial of drug for Covid-19-linked GI infections to Ukraine

    UNICEF and Moderna Announce Long Term Agreement to Supply Vaccine on Behalf of the COVAX Facility

    Moderna and Canada Announce Collaboration to Bring mRNA Manufacturing to Canada

    DCGI nod to Serum-Oxford covid-19 vaccine for phase 2, 3 clinical trials in India

    INOVIO Doses First Participant in Phase 2 Trial for its DNA Vaccine Against Middle East Respiratory Syndrome (MERS), a Coronavirus Disease

    U.S. FDA Approves DARZALEX Split-Dosing Regimen

    Lilly and Incyte’s baricitinib reduced deaths among patients with COVID-19 receiving invasive mechanical ventilation

    BioMed X, Janssen Begin Autoimmunity and Drug Delivery Research

    BioMed X, Janssen Begin Autoimmunity and Drug Delivery Research

    Amgen Receives NMPA Approval For Repatha In China To Reduce The Risk Of Cardiovascular Events

    Amgen Investing $550M in New Biomanufacturing Facility

    Regeneron and AstraZeneca to Research, Develop and Commercialize New Small Molecule Medicines for Obesity

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
  • Home
  • Drug Development
    • All
    • Clinical Trials
    • FDA Approvals
    • Research & Development
    Sorrento and Mount Sinai Team Up for Antibody Cocktail COVI-SHIELD Project

    I-Mab Reports Positive Interim Analysis from Phase 2/3 Study of its GM-CSF Antibody Plonmarlimab to Treat Patients with Severe COVID-19

    Care Access Research Launches Alliance to Provide Infrastructure for COVID-19 Trials

    Valneva Initiates Further Phase 3 Clinical Trial for its COVID-19 Vaccine Candidate

    Charities Pay $6 Million to Settle Medicare Kickback Allegations in Pharma Probe

    AzurRx expands trial of drug for Covid-19-linked GI infections to Ukraine

    UNICEF and Moderna Announce Long Term Agreement to Supply Vaccine on Behalf of the COVAX Facility

    Moderna and Canada Announce Collaboration to Bring mRNA Manufacturing to Canada

    DCGI nod to Serum-Oxford covid-19 vaccine for phase 2, 3 clinical trials in India

    INOVIO Doses First Participant in Phase 2 Trial for its DNA Vaccine Against Middle East Respiratory Syndrome (MERS), a Coronavirus Disease

    U.S. FDA Approves DARZALEX Split-Dosing Regimen

    Lilly and Incyte’s baricitinib reduced deaths among patients with COVID-19 receiving invasive mechanical ventilation

    BioMed X, Janssen Begin Autoimmunity and Drug Delivery Research

    BioMed X, Janssen Begin Autoimmunity and Drug Delivery Research

    Amgen Receives NMPA Approval For Repatha In China To Reduce The Risk Of Cardiovascular Events

    Amgen Investing $550M in New Biomanufacturing Facility

    Regeneron and AstraZeneca to Research, Develop and Commercialize New Small Molecule Medicines for Obesity

  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us
No Result
View All Result
Pharma Advancement
No Result
View All Result
Home Drug Development Clinical Trials

New Analysis Supports Medisafe’s Impact on Medication Persistence, Adherence

Content Team by Content Team
9th July 2021
in Clinical Trials, Drug Development, News
New Analysis Supports Medisafe's Impact on Medication Persistence, Adherence
Previous Post

Cellenkos Selects Cryoport to Support On-Demand, Flexible COVID-19 Therapy Shipments to Patients in Need

 Next Post

Fujitsu Japan Embarks on Joint Research for COVID-19 Therapies Using Fugaku

Related Posts

Sorrento and Mount Sinai Team Up for Antibody Cocktail COVI-SHIELD Project
Clinical Trials

I-Mab Reports Positive Interim Analysis from Phase 2/3 Study of its GM-CSF Antibody Plonmarlimab to Treat Patients with Severe COVID-19

12th August 2021
DFE Pharma demonstrates Impact of Powder Properties on the Rheological Behavior of Excipients
News

DFE Pharma demonstrates Impact of Powder Properties on the Rheological Behavior of Excipients

12th August 2021
Care Access Research Launches Alliance to Provide Infrastructure for COVID-19 Trials
Clinical Trials

Valneva Initiates Further Phase 3 Clinical Trial for its COVID-19 Vaccine Candidate

12th August 2021
Charities Pay $6 Million to Settle Medicare Kickback Allegations in Pharma Probe
Clinical Trials

AzurRx expands trial of drug for Covid-19-linked GI infections to Ukraine

12th August 2021
UNICEF and Moderna Announce Long Term Agreement to Supply Vaccine on Behalf of the COVAX Facility
Drug Development

Moderna and Canada Announce Collaboration to Bring mRNA Manufacturing to Canada

12th August 2021
Johnson & Johnsons's single-dose COVID-19 vaccine gets approval for emergency use in India
Featured

Johnson & Johnson’s single-dose COVID-19 vaccine gets approval for emergency use in India

12th August 2021
Next Post
Fujitsu Japan Embarks on Joint Research for COVID-19 Therapies Using Fugaku

Fujitsu Japan Embarks on Joint Research for COVID-19 Therapies Using Fugaku

Latest News

Trends in new medications demand innovative patient-friendly drug delivery systems
Trends

Trends in new medications demand innovative patient-friendly drug delivery systems

17th August 2021
Sorrento and Mount Sinai Team Up for Antibody Cocktail COVI-SHIELD Project
Clinical Trials

I-Mab Reports Positive Interim Analysis from Phase 2/3 Study of its GM-CSF Antibody Plonmarlimab to Treat Patients with Severe COVID-19

12th August 2021
Glenmark and SaNOtize to commercialize Nitric Oxide Nasal Spray for COVID-19 treatment in India and other Asian markets
Press Statements

Glenmark and SaNOtize to commercialize Nitric Oxide Nasal Spray for COVID-19 treatment in India and other Asian markets

12th August 2021
DFE Pharma demonstrates Impact of Powder Properties on the Rheological Behavior of Excipients
News

DFE Pharma demonstrates Impact of Powder Properties on the Rheological Behavior of Excipients

12th August 2021
Care Access Research Launches Alliance to Provide Infrastructure for COVID-19 Trials
Clinical Trials

Valneva Initiates Further Phase 3 Clinical Trial for its COVID-19 Vaccine Candidate

12th August 2021
Pharma Advancement

About Us

Pharma Advancement is a leading Pharma information centric website. On one side Pharmaadvancement.com has established itself as one of the most efficient and comprehensive source of Pharma information online, dedicated to providing decision makers in all the Pharma industry sectors with reliable, accurate and useful insights into happenings in the Pharma sector.

Qucik Links

  • Drug Development
  • Manufacturing
  • News
  • Events & Conferences
  • Newsletter Archive

Resources

  • Advertise with us
  • Contact Us
  • Download Mediapack

System

  • Search
  • Sitemap
  • RSS Feed

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

No Result
View All Result
  • Home
  • Drug Development
  • Manufacturing
  • Supply Chain
  • Facilities
  • Health & Nutrition
  • Events
  • Contact Us

© 2017 Copyright © Valuemediaservices 2017 All rights reserved.

Login to your account below

Forgotten Password?

Fill the forms bellow to register

All fields are required. Log In

Retrieve your password

Please enter your username or email address to reset your password.

Log In